Novo, Lilly collaborate with Waltz Health to sell weight-loss drugs directly to employers

Core Insights - Digital health company Waltz Health has launched a program to provide popular weight-loss drugs from Novo Nordisk and Eli Lilly directly to employers, aiming to bypass traditional drug sales channels [1] Company Summary - Waltz Health is focusing on direct sales of weight-loss medications, which may disrupt the conventional pharmaceutical distribution model [1] - The initiative targets employers, potentially expanding access to these medications for employees [1] Industry Summary - The move reflects a growing trend in the digital health sector to streamline access to medications and enhance employer-sponsored health programs [1] - The partnership with major pharmaceutical companies like Novo Nordisk and Eli Lilly indicates a significant shift in how weight-loss drugs are marketed and distributed [1]